Latest News & Features
Big Pharma
Common themes, in particular in the context of second medical use claims and dosage regimes, are on the radar of the UK courts, as Jennifer Antcliff and Dennis Waller report. 19 February 2014
Biotechnology
Second and further medical use claims provide companies and patent lawyers with interesting opportunities, as Caroline Pallard explains. 19 February 2014
Big Pharma
The CJEU has delivered its judgment in three SPC cases, in an attempt to address fundamental issues in the SPC Regulation, as well as uncertainties arising from earlier rulings. Although questions have been answered, others have been raised, say David Carling and Michael Pears. 19 February 2014
Americas
Novartis has announced it will acquire biotechnology company CoStim for an undisclosed sum. 18 February 2014
Asia-Pacific
Australia’s antitrust regulator has launched proceedings against Pfizer’s Australian arm, accusing it of abusing its power when supplying cholesterol-lowering drug atorvastatin to pharmacies. 18 February 2014
Biotechnology
Baker & McKenzie LLP has added to its IP team with the appointment of Hiroshi Sheraton as partner in its London office. 17 February 2014
Americas
Humanitarian organisation Médecins Sans Frontières has criticised the US for pressuring the Indian government to review its patent policies. 17 February 2014
Americas
Myriad and its rival genetic diagnostics company Gene by Gene have agreed to settle their patent infringement case related to BRCA tests. 13 February 2014
Americas
The US Chamber of Commerce has criticised India’s “recent pattern of pharma patent denials”, which it says “are not about access to medicine”. 12 February 2014
Americas
Pharmaceutical company Merck and Samsung Bioepis, a joint venture between South Korean firm Samsung and Biogen, have agreed to work on a diabetes treatment. 11 February 2014